{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:25:22Z","timestamp":1792250722381,"version":"4.4.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.celrep.2022.111883","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T15:37:44Z","timestamp":1672155464000},"page":"111883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndrome"],"prefix":"10.1016","volume":"41","author":[{"given":"Paula","family":"Araya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohl T.","family":"Kinning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith P.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross E.","family":"Granrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda A.","family":"Enriquez-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayleigh","family":"Worek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly D.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela L.","family":"Rachubinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Wolter-Warmerdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Galbraith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huntington","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-1941","authenticated-orcid":false,"given":"Joaquin M.","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2022.111883_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/gim.2016.127","article-title":"Estimation of the number of people with Down syndrome in the United States","volume":"19","author":"de Graaf","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.celrep.2022.111883_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.celrep.2022.111883_bib3","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/gim.2016.23","article-title":"Low risk of solid tumors in persons with Down syndrome","volume":"18","author":"Hasle","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.celrep.2022.111883_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/dmcn.12868","article-title":"Morbidity and medication in a large population of individuals with Down syndrome compared to the general population","volume":"58","author":"Alexander","year":"2016","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.celrep.2022.111883_bib5","first-page":"86","article-title":"Prevalence of common disease conditions in a large cohort of individuals with down syndrome in the United States","volume":"8","author":"Chicoine","year":"2021","journal-title":"J.\u00a0Patient. Cent. Res. Rev."},{"key":"10.1016\/j.celrep.2022.111883_bib6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1474-4422(10)70112-5","article-title":"Cognitive deficits and associated neurological complications in individuals with Down's syndrome","volume":"9","author":"Lott","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.celrep.2022.111883_bib7","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1523\/JNEUROSCI.3728-10.2010","article-title":"Down syndrome: from understanding the neurobiology to therapy","volume":"30","author":"Gardiner","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.celrep.2022.111883_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-444-54299-1.00006-6","article-title":"Neurological phenotypes for Down syndrome across the life span","volume":"197","author":"Lott","year":"2012","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.celrep.2022.111883_bib9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/alz.12112","article-title":"Further understanding the connection between Alzheimer's disease and Down syndrome","volume":"16","author":"Snyder","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.celrep.2022.111883_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13195-020-00601-w","article-title":"Relevance of biomarkers across different neurodegenerative diseases","volume":"12","author":"Ehrenberg","year":"2020","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.celrep.2022.111883_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41582-020-0348-0","article-title":"An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders","volume":"16","author":"Ashton","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.celrep.2022.111883_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13195-020-00593-7","article-title":"Dynamics of plasma biomarkers in Down syndrome: the relative levels of A\u03b242 decrease with age, whereas NT1 tau and NfL increase","volume":"12","author":"Mengel","year":"2020","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.celrep.2022.111883_bib13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1474-4422(18)30285-0","article-title":"Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study","volume":"17","author":"Fortea","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.celrep.2022.111883_bib14","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/S0140-6736(20)30689-9","article-title":"Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study","volume":"395","author":"Fortea","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2022.111883_bib15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(21)00129-0","article-title":"Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study","volume":"20","author":"Carmona-Iragui","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.celrep.2022.111883_bib16","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.3390\/jcm10091907","article-title":"Cross-Sectional exploration of plasma biomarkers of Alzheimer\u2019s disease in down syndrome: early data from the longitudinal investigation for enhancing down syndrome research (LIFE-DSR) study","volume":"10","author":"Hendrix","year":"2021","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.celrep.2022.111883_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13195-018-0367-x","article-title":"Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome","volume":"10","author":"Strydom","year":"2018","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.celrep.2022.111883_bib18","doi-asserted-by":"crossref","first-page":"e0211575","DOI":"10.1371\/journal.pone.0211575","article-title":"Plasma neurofilament light chain: a potential prognostic biomarker of dementia in adult Down syndrome patients","volume":"14","author":"Shinomoto","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2022.111883_bib19","first-page":"e12057","article-title":"Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome","volume":"12","author":"Henson","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.celrep.2022.111883_bib20","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","article-title":"A multicentre validation study of the diagnostic value of plasma neurofilament light","volume":"12","author":"Ashton","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111883_bib21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3233\/JAD-201167","article-title":"Plasma total-tau and neurofilament light chain as diagnostic biomarkers of Alzheimer's disease dementia and mild cognitive impairment in adults with down syndrome","volume":"79","author":"Petersen","year":"2021","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.celrep.2022.111883_bib22","doi-asserted-by":"crossref","first-page":"84489","DOI":"10.18632\/oncotarget.21060","article-title":"Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2022.111883_bib23","doi-asserted-by":"crossref","first-page":"14818","DOI":"10.1038\/s41598-017-13858-3","article-title":"Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation","volume":"7","author":"Sullivan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2022.111883_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fped.2020.00073","article-title":"Immune dysregulation in children with down syndrome","volume":"8","author":"Huggard","year":"2020","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.celrep.2022.111883_bib25","doi-asserted-by":"crossref","first-page":"154938","DOI":"10.1016\/j.cyto.2019.154938","article-title":"Increased systemic inflammation in children with Down syndrome","volume":"127","author":"Huggard","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.celrep.2022.111883_bib26","doi-asserted-by":"crossref","first-page":"24231","DOI":"10.1073\/pnas.1908129116","article-title":"Trisomy 21 dysregulates T\u00a0cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity","volume":"116","author":"Araya","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111883_bib27","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.celrep.2019.10.038","article-title":"Mass cytometry reveals global immune remodeling with multi-lineage hypersensitivity to type I interferon in down syndrome","volume":"29","author":"Waugh","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111883_bib28","doi-asserted-by":"crossref","first-page":"702685","DOI":"10.3389\/fncel.2021.702685","article-title":"Astrocytes in down syndrome across the lifespan","volume":"15","author":"Ponroy Bally","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.celrep.2022.111883_bib29","doi-asserted-by":"crossref","first-page":"170276","DOI":"10.1155\/2012\/170276","article-title":"Neuroinflammation in the aging down syndrome brain; lessons from Alzheimer's disease","volume":"2012","author":"Wilcock","year":"2012","journal-title":"Curr. Gerontol. Geriatr. Res."},{"key":"10.1016\/j.celrep.2022.111883_bib30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ajhg.2020.10.001","article-title":"Apigenin as a candidate prenatal treatment for trisomy 21: effects in human amniocytes and the Ts1Cje mouse model","volume":"107","author":"Guedj","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.celrep.2022.111883_bib31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neuron.2020.09.010","article-title":"Rescuing over-activated microglia restores cognitive performance in juvenile animals of the Dp(16) mouse model of down syndrome","volume":"108","author":"Pinto","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2022.111883_bib32","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1111\/j.0953-816X.2004.03439.x","article-title":"Minocycline protects basal forebrain cholinergic neurons from mu p75-saporin immunotoxic lesioning","volume":"19","author":"Hunter","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.celrep.2022.111883_bib33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.expneurol.2008.11.021","article-title":"Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model","volume":"216","author":"Lockrow","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.celrep.2022.111883_bib34","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3389\/fendo.2019.00822","article-title":"IGFBP-2 signaling in the brain: from brain development to higher order brain functions","volume":"10","author":"Khan","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.celrep.2022.111883_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuroscience.2016.03.056","article-title":"The role of Insulin-Like Growth Factor 1 (IGF-1) in brain development, maturation and neuroplasticity","volume":"325","author":"Dyer","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.celrep.2022.111883_bib36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fncel.2017.00014","article-title":"Insulin-like growth factor 1: at the crossroads of brain development and aging","volume":"11","author":"Wrigley","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.celrep.2022.111883_bib37","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/s41593-018-0266-2","article-title":"Haploinsufficiency of the intellectual disability gene SETD5 disturbs developmental gene expression and cognition","volume":"21","author":"Deliu","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2022.111883_bib38","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.3390\/ijms21197108","article-title":"RET receptor tyrosine kinase: role in neurodegeneration, obesity, and cancer","volume":"21","author":"Mahato","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2022.111883_bib39","doi-asserted-by":"crossref","first-page":"11843","DOI":"10.1016\/S0021-9258(18)80143-0","article-title":"High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum","volume":"264","author":"Baxter","year":"1989","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2022.111883_bib40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fendo.2011.00095","article-title":"Genetic defects in the growth hormone-IGF-I Axis causing growth hormone insensitivity and impaired linear growth","volume":"2","author":"Savage","year":"2011","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.celrep.2022.111883_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fendo.2018.00117","article-title":"IGF-binding proteins: why do they exist and why are there so many?","volume":"9","author":"Allard","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.celrep.2022.111883_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00406-014-0550-4","article-title":"Complexin2 modulates working memory-related neural activity in patients with schizophrenia","volume":"265","author":"Hass","year":"2015","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.celrep.2022.111883_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/1176934318775081","article-title":"Molecular evolution and functional divergence of the IgLON family","volume":"14","author":"Kubick","year":"2018","journal-title":"Evol. Bioinform. Online"},{"key":"10.1016\/j.celrep.2022.111883_bib44","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/ncomms2443","article-title":"Doublecortin-like kinase enhances dendritic remodelling and negatively regulates synapse maturation","volume":"4","author":"Shin","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111883_bib45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.celrep.2022.111883_bib46","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nrendo.2013.67","article-title":"The GH\/IGF-1 axis in ageing and longevity","volume":"9","author":"Junnila","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.celrep.2022.111883_bib47","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1073\/pnas.96.12.7088","article-title":"Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice","volume":"96","author":"Sj\u00f6gren","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111883_bib48","doi-asserted-by":"crossref","first-page":"E1988","DOI":"10.1210\/jc.2013-3814","article-title":"Ternary complex formation and IGFBP-3 proteolytic activity during childhood: age-dependent changes","volume":"99","author":"Renes","year":"2014","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.celrep.2022.111883_bib49","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.4049\/jimmunol.162.7.4285","article-title":"Eotaxin activates T\u00a0cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4","volume":"162","author":"Jinquan","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111883_bib50","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5114\/ceji.2020.103422","article-title":"Chronic inflammation and the growth hormone\/insulin-like growth factor-1 axis","volume":"45","author":"Witkowska-S\u0119dek","year":"2020","journal-title":"Cent. Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2022.111883_bib51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/107999003321829944","article-title":"TNF-alpha and growth hormone resistance in patients with chronic liver disease","volume":"23","author":"Picardi","year":"2003","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.celrep.2022.111883_bib52","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1053\/j.gastro.2005.02.003","article-title":"Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis","volume":"128","author":"DiFedele","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.celrep.2022.111883_bib53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ana.25524","article-title":"PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation","volume":"86","author":"Chelban","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2022.111883_bib54","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1542\/peds.81.1.102","article-title":"Growth charts for children with Down syndrome: 1\u00a0month to 18 years of age","volume":"81","author":"Cronk","year":"1988","journal-title":"Pediatrics"},{"key":"10.1016\/j.celrep.2022.111883_bib55","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ejpn.2016.08.005","article-title":"Treatment of autistic spectrum disorder with insulin-like growth factors","volume":"20","author":"Riikonen","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.celrep.2022.111883_bib56","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fnins.2016.00450","article-title":"Insulin-like growth factor 1 and related compounds in the treatment of childhood-onset neurodevelopmental disorders","volume":"10","author":"Vahdatpour","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.celrep.2022.111883_bib57","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neubiorev.2016.01.001","article-title":"The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders","volume":"63","author":"Costales","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.celrep.2022.111883_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ghir.2017.04.003","article-title":"Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH\/IGF-1 axis","volume":"34","author":"Raisingani","year":"2017","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.celrep.2022.111883_bib59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ghir.2017.12.005","article-title":"Growth hormone and insulin-like growth factor-I axis in type 1 diabetes","volume":"38","author":"Nambam","year":"2018","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.celrep.2022.111883_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/08916934.2014.976631","article-title":"Inhibition of the insulin-like growth factor system is a potential therapy for rheumatoid arthritis","volume":"48","author":"Suzuki","year":"2015","journal-title":"Autoimmunity"},{"key":"10.1016\/j.celrep.2022.111883_bib61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.21037\/arh.2019.03.02","article-title":"The role of insulin growth factors in autoimmune diseases","volume":"3","author":"Skarlis","year":"2019","journal-title":"Ann. Res. Hosp."},{"key":"10.1016\/j.celrep.2022.111883_bib62","first-page":"6057589","article-title":"Insulin-like growth factor-1 signaling in lung development and inflammatory lung diseases","volume":"2018","author":"Wang","year":"2018","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.celrep.2022.111883_bib63","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/apa.13350","article-title":"Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant development","volume":"105","author":"Hellstr\u00f6m","year":"2016","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.celrep.2022.111883_bib64","doi-asserted-by":"crossref","first-page":"e14862","DOI":"10.1097\/MD.0000000000014862","article-title":"Serum levels of insulin-like growth factor 1 are negatively associated with log transformation of thyroid-stimulating hormone in Graves' disease patients with hyperthyroidism or subjects with euthyroidism: a prospective observational study","volume":"98","author":"Tseng","year":"2019","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.celrep.2022.111883_bib65","article-title":"Interferon receptor gene dosage determines diverse hallmarks of Down syndrome","author":"Waugh","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2022.111883_bib66","doi-asserted-by":"crossref","first-page":"108407","DOI":"10.1016\/j.celrep.2020.108407","article-title":"JAK1 inhibition blocks lethal immune hypersensitivity in a mouse model of down syndrome","volume":"33","author":"Tuttle","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111883_bib67","doi-asserted-by":"crossref","first-page":"e16220","DOI":"10.7554\/eLife.16220","article-title":"Trisomy 21 consistently activates the interferon response","volume":"5","author":"Sullivan","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2022.111883_bib68","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1038\/s41467-019-12739-9","article-title":"Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors","volume":"10","author":"Powers","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111883_bib69","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jdcr.2019.02.007","article-title":"Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata","volume":"5","author":"Rachubinski","year":"2019","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.celrep.2022.111883_bib70","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1093\/rheumatology\/keab203","article-title":"JAK inhibition for treatment of psoriatic arthritis in Down syndrome","volume":"60","author":"Pham","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.celrep.2022.111883_bib71","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1210\/en.2008-0920","article-title":"Expanding the mind: insulin-like growth factor I and brain development","volume":"149","author":"Joseph D'Ercole","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.celrep.2022.111883_bib72","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2114326118","article-title":"Altered cell and RNA isoform diversity in aging Down syndrome brains","volume":"118","author":"Palmer","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111883_bib73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1530\/JOE-11-0200","article-title":"Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence","volume":"211","author":"Yan","year":"2011","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.celrep.2022.111883_bib74","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/sj.mp.4002076","article-title":"Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects","volume":"12","author":"Trejo","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.celrep.2022.111883_bib75","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1677\/joe.1.06631","article-title":"Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice","volume":"189","author":"Svensson","year":"2006","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.celrep.2022.111883_bib76","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/138955712798868995","article-title":"GPE and GPE analogues as promising neuroprotective agents","volume":"12","author":"Cacciatore","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.celrep.2022.111883_bib77","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1479-5876-10-224","article-title":"Human conditions of insulin-like growth factor-I (IGF-I) deficiency","volume":"10","author":"Puche","year":"2012","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.celrep.2022.111883_bib78","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/adc.61.1.48","article-title":"Growth and somatomedin responses to growth hormone in Down's syndrome","volume":"61","author":"Anner\u00e9n","year":"1986","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.celrep.2022.111883_bib79","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ghir.2009.11.002","article-title":"Normal growth hormone secretion in overweight young adults with Down syndrome","volume":"20","author":"Myrelid","year":"2010","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.celrep.2022.111883_bib80","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/adc.47.252.307","article-title":"Plasma growth hormone in patients with chromosomal anomalies","volume":"47","author":"Ruvalcaba","year":"1972","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.celrep.2022.111883_bib81","first-page":"803","article-title":"Somatomedins in Down's syndrome","volume":"18","author":"Sara","year":"1983","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.celrep.2022.111883_bib82","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0022-3476(05)82068-2","article-title":"Treatment of children with Down syndrome and growth retardation with recombinant human growth hormone","volume":"119","author":"Torrado","year":"1991","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.celrep.2022.111883_bib83","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/adc.80.4.334","article-title":"Growth hormone treatment in young children with Down's syndrome: effects on growth and psychomotor development","volume":"80","author":"Anner\u00e9n","year":"1999","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.celrep.2022.111883_bib84","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1651-2227.2009.01679.x","article-title":"Late effects of early growth hormone treatment in Down syndrome","volume":"99","author":"Myrelid","year":"2010","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.celrep.2022.111883_bib85","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1097\/01.CCM.0000215113.66070.E0","article-title":"Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling","volume":"34","author":"Yumet","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.celrep.2022.111883_bib86","doi-asserted-by":"crossref","first-page":"E1856","DOI":"10.1152\/ajpendo.00581.2006","article-title":"Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2\/STAT5 signal transduction and STAT5b DNA binding","volume":"292","author":"Chen","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.celrep.2022.111883_bib87","doi-asserted-by":"crossref","first-page":"E186","DOI":"10.1152\/ajpendo.00652.2013","article-title":"Distinct mechanisms of induction of hepatic growth hormone resistance by endogenous IL-6, TNF-\u03b1, and IL-1\u03b2","volume":"307","author":"Zhao","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.celrep.2022.111883_bib88","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1172\/JCI10994","article-title":"TNF-alpha downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding","volume":"107","author":"Denson","year":"2001","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2022.111883_bib89","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1210\/endo.142.11.8511","article-title":"Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis","volume":"142","author":"De Benedetti","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.celrep.2022.111883_bib90","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fendo.2013.00006","article-title":"Anabolic effects of IGF-1 signaling on the skeleton","volume":"4","author":"Tahimic","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.celrep.2022.111883_bib91","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1006\/jmcc.1999.1036","article-title":"Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease","volume":"31","author":"Ren","year":"1999","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.celrep.2022.111883_bib92","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1084\/jem.20161596","article-title":"Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview","volume":"213","author":"Rodero","year":"2016","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.111883_bib93","first-page":"543","article-title":"Advances in human proteomics at high scale with the SOMAscan proteomics platform","volume":"29","author":"Gold","year":"2012","journal-title":"N.\u00a0Biotechnol."},{"key":"10.1016\/j.celrep.2022.111883_bib95","series-title":"R: A Language and Environment for Statistical Computing","year":"2020"},{"key":"10.1016\/j.celrep.2022.111883_bib96","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2022.111883_bib97","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111883_bib98","article-title":"An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation","author":"Sergushichev","year":"2016","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2022.111883_bib99","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221112472201779X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221112472201779X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:57:43Z","timestamp":1714784263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221112472201779X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":98,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S221112472201779X"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2022.111883","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndrome","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2022.111883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"111883"}}